Screening Triage and Risk Stratification

RecruitingOBSERVATIONAL
Enrollment

5,000

Participants

Timeline

Start Date

February 27, 2023

Primary Completion Date

February 28, 2027

Study Completion Date

February 28, 2027

Conditions
Cervix CancerHPV TestingPostmenopausal Women
Interventions
OTHER

cytology, p16/ki67 dual stain cytology (DS), extended genotyping, DNA methylation, viral load,

p16/Ki67 dual stain cytology, extended genotyping and DNA methylation will be performed from the residual cell-pellet from the HPV-positive screening samples. If no cytology-triage testing is performed as a part of the screening algorithm, a cytology will be performed at inclusion. If any residual material is left after DS, extended genotyping and DNA methylation, it will be stores at -80 degrees for future purposes.

Trial Locations (1)

8930

RECRUITING

Department of Pathology, Randers

All Listed Sponsors
collaborator

Randers Regional Hospital

OTHER

lead

University of Aarhus

OTHER